Research graph
References from Predicting median survival from early follow-up data: opportunities, limitations, and extensions. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1093/jnci/djag146 · 2026 · Admitted local publication
Extrapolating empirical long-term survival data: the impact of updated follow-up data and parametric extrapolation methods on survival estimates in multiple myeloma
10.1186/s12874-023-01952-2 · 2023 · External reference
Parametric survival extrapolation of early survival data in economic analyses: a comparison of projected versus observed updated survival
10.1016/j.jval.2021.10.004 · 2022 · External reference
Applying state-of-the-art survival extrapolation techniques to the evaluation of CAR-T therapies: evidence from a systematic literature review
10.1007/s12325-021-01841-4 · 2021 · External reference
The acceptance of overall survival extrapolation methods in solid tumor treatments by health technology assessment agencies in England, France, and Australia between 2017 and 2022
10.1177/0272989x251351635 · 2025 · External reference
Exponential decay nonlinear regression analysis of patient survival curves: preliminary assessment in non-small cell lung cancer
10.1016/j.lungcan.2010.05.012 · 2011 · External reference
Comparison of the restricted mean survival time with the hazard ratio in superiority trials with a time-to-event end point
10.1002/pst.1846 · 2018 · External reference
Are restricted mean survival time methods especially useful for noninferiority trials?
10.1177/1740774520976576 · 2021 · External reference
Reconstructing patient level survival data from published Kaplan-Meier curves
10.1016/j.conctc.2025.101542 · 2025 · External reference
IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves
10.1186/s12874-021-01308-8 · 2021 · External reference
Unresolved reference
2026 · External reference
Reflections on FDA draft guidance on bayesian methods in trials-protecting scientific integrity and evidentiary standards
10.1001/jama.2026.4175 · 2026 · External reference
FDA draft guidance for the use of Bayesian methods in clinical trials
10.1001/jama.2026.4178 · 2026 · External reference
Embracing Bayesian methods in clinical trials: FDA’s long-awaited draft guidance
10.1001/jama.2026.4179 · 2026 · External reference
10.1007/978-0-8176-4775-9_4
10.1007/978-0-8176-4775-9_4 · 1992 · External reference
